This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Johannes Gutenberg-Universität Mainz. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Renate Engel: Innovator in Genetic Constructs
Introduction
Renate Engel is a notable inventor based in Mainz, Germany. She has made significant contributions to the field of genetic engineering, particularly in the development of antigen-recognizing constructs. Her work focuses on enhancing the efficacy of T-cell responses through innovative methods.
Latest Patents
Renate Engel holds a patent titled "Method for improving the specific effector function of single-chain antigen-recognizing genetic constructs (scARC) through murinization thereof." This invention relates to a method for producing a cell line that expresses a stabilized functional single-chain antigen-recognizing genetic construct. The method involves co-expressing genetic constructs that contain specific amino acid exchanges, which are crucial for recognizing tumor-associated peptide antigens.
Career Highlights
Engel's career is marked by her dedication to advancing genetic research. She has been instrumental in developing techniques that improve the functionality of T-cell receptors, which are vital for targeted cancer therapies. Her innovative approaches have the potential to enhance the effectiveness of immunotherapies.
Collaborations
Renate Engel collaborates with esteemed colleagues, including Ralf-Holger Voss and Simone Thomas. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of genetic research.
Conclusion
Renate Engel's contributions to genetic engineering and her innovative patent demonstrate her commitment to advancing medical science. Her work has the potential to significantly impact cancer treatment and immunotherapy.